Research output per year
Research output per year
Fingerprint
Dive into the research topics where Robert J Chilton is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Beyond the myocardium: Sodium-glucose co-transporter-2 inhibitors in heart failure
Chilton, R. J., May 2021, In: Diabetes, Obesity and Metabolism. 23, 5, p. 1215-1218 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Neural tone and cardio-renal outcomes in patients with type 2 diabetes mellitus: a review of the literature with a focus on SGLT2 inhibitors
Nashawi, M., Sheikh, O., Battisha, A., Ghali, A. & Chilton, R., May 2021, In: Heart Failure Reviews. 26, 3, p. 643-652 10 p.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
Real-world evidence and product development: Opportunities, challenges and risk mitigation
Naidoo, P., Bouharati, C., Rambiritch, V., Jose, N., Karamchand, S., Chilton, R. & Leisegang, R., 2021, (Accepted/In press) In: Wiener Klinische Wochenschrift.Research output: Contribution to journal › Review article › peer-review
Open Access -
Sglt2 inhibitors: A narrative review of efficacy and safety
Nelinson, D. S., Sosa, J. M. & Chilton, R. J., Feb 2021, In: Journal of the American Osteopathic Association. 121, 2, p. 229-239 11 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Sodium-glucose co-transporter 2 inhibitors and diabetic retinopathy: Insights into preservation of sight and looking beyond
Lahoti, S., Nashawi, M., Sheikh, O., Massop, D., Mir, M. & Chilton, R., 2021, (Accepted/In press) In: Cardiovascular Endocrinology and Metabolism. p. 3-13 11 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations
Press / Media
-
SGLT2 inhibitors may have great potential in reducing HF in diabetes
7/23/19 → 7/24/19
2 items of Media coverage
Press/Media: Press / Media
-
Cardiologists Must 'Get Up To Speed' on Treating Diabetes
6/19/19 → 6/20/19
2 items of Media coverage
Press/Media: Press / Media
-
Strategic Management to Optimize Response To Cardiac Resynchronization Therapy; SMART CRT
10/2/18
1 item of Media coverage
Press/Media: Press / Media
-
Orexigen Therapeutics Announces Multiple Contrave Data Presentations at the 29th Annual Scientific Meeting of The Obesity Society
9/30/17
1 item of Media coverage
Press/Media: Press / Media